Kumho Mitsui Chemicals will invest 400 billion won to expand MDI production
Kumho Mitsui Chemicals recently stated that it will invest about 400 billion won (US$358.1 million) to expand its chemical manufacturing plant in the southwestern region of South Korea.
The joint venture between South Korean synthetic rubber manufacturer Kumho Petrochemical and Japan’s Mitsui Chemicals said its shareholders have approved an investment plan to expand the methyl diphenyl diisocyanate (MDI) plant in Yeosu, 455 kilometers southwest of Seoul.
MDI is a core material of polyurethane and is used in various products, including refrigerators, building materials, automotive interior and exterior materials, and LNG ships.
Kumho Mitsui Chemicals stated that when the expansion is completed in 2024, the annual production capacity of Kumho Mitsui Chemicals' MDI will increase from the current 400,000 tons to 610,000 tons, and it is expected to increase sales by more than 1.5 trillion won.
2026-10-16
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Recently Wanhua Chemical had 1 large transaction with a transaction amount of 4,689,000 Yuan!
-
Cost increase prompts Covestro to re-examine the location plan of MDI factory
-
Add 600,000 tons of MDI production capacity! Wanhua Chemical’s global MDI production capacity will account for 32%!
-
Dow Swings from an $801 Million Loss to an $802 Million Profit as Hormuz Disruption Lifts Polyethylene Prices
-
Türkiye Advances $3 Billion Petrochemical Cluster Targeting 17% of Domestic Polypropylene Demand
-
Argentina to Build Latin America’s Largest Urea Plant Under €1.3 Billion Contract
-
BASF Evaluates New MDI Production Complex in India, Secures Dahej Site
-
Huntsman Issues Two Consecutive MDI Price Hike Notices: €250 Increase in Europe, $300 Increase in India
-
Dover to Acquire Cloeren and Expand Its Polymer-Extrusion Equipment Portfolio
-
Croda’s First-Half Profit Outpaces Sales as Beauty Actives Grow 19%
Recommend Reading
-
argenx to Acquire Forte Biosciences for $2.2 Billion in Major Autoimmune Antibody Deal
-
GACL Approves Additional Hydrochloric Acid Unit at Dahej
-
When the Chemical Industry Is No Longer Highly Profitable: Sinochem International’s 2.4 Billion Yuan Loss Reveals the Truth About Industry Cycles
-
Brenntag Expands Distribution of Givaudan’s Active Beauty Ingredients to Malaysia and Singapore
-
Profit Crushed, Layoffs and Restructuring Follow: What WACKER Chemie’s 2025 Performance Reveals
-
This Week's Styrene Market Continues to Show Weakness (11.3-11.7)
-
This Week's Pure Benzene Market Prices Show Slight Fluctuations (Nov. 3–Nov. 8)
-
Supply Contraction Drives Dichloromethane Prices Up in China
-
FDA Revokes Orange B Authorization and Proposes Removing Citrus Red No. 2
-
EFSA’s Updated Food-Additive Application Guidance Takes Effect